Tu sei qui: Home > CANNABINOIDS > Treating depression with cannabinoids

Cannabinoids 2008;3(2):8-10 (22 June 2008)

Original article

Treating depression with cannabinoids

Kurt Blaas

Lindengasse 27/10, 1070 Vienna, Austria, drblaas@blowdoc.at

Although a variety of drugs are available for the treatment of depression, therapy is not effective in all cases and finding alternative options is desirable. Results from animal studies, anecdotal ex-perience reported by patients using cannabis and observations from clinical studies where can-nabinoids were used in serious diseases suggest an anti-depressive potential of cannabinoid recep-tor agonists. From 2003 to 2006, 75 patients suffering from depression, stress and burnout syn-drome were successfully treated in a practice for general medicine with the cannabis ingredient dronabinol, alone or in combination with other antidepressants. Two case studies will be pre-sented. The presented observations suggest that dronabinol has an antidepressive potential that can readily be used in medical practice.

Depression, burnout, cannabinoid, cannabis, dronabinol

PDF del testo completo ]

IACM Conference 2019

 The IACM Conference 2019 will be held on October 31 - November 2, 2019, at Estrel Hotel, Berlin, Germany.

Conferenze supportate

STCM Conference, 19 January 2019, University Hospital Bern, Switzerland


Cann10, 14-16 October 2018, Tel Aviv Israel.


Members only

 Please click here to visit the Members Only Area with a film to honour Prof Raphael Mechoulam, 
Please click here to become a member.

IACM on Twitter

Follow us on twitter @IACM_Bulletin where you can send us inquiries and receive updates on research studies and news articles.